Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163640 · ClinicalTrials.gov registry record · NA
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT04163640 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 90 participants.
The verdict
NCT04163640, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The objective of this study is to perform a prospective randomized controlled trial seeking to characterize the effects of intra-ovarian injection of platelet rich plasma (PRP) on biomarkers of ovarian reserve as well as IVF outcomes in women with primary ovarian insufficiency (POI) and poor ovarian response (POR) who decline the use of an egg donor to establish a pregnancy.
Interventions
- OTHER intra-ovarian platelet rich plasma injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2023-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04163640
The ClinicalTrials.gov registry entry for NCT04163640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intra-ovarian platelet rich plasma injection is the first listed.
NCT04163640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04163640 about?
NCT04163640 is a clinical study titled "Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response". The objective of this study is to perform a prospective randomized controlled trial seeking to characterize the effects of intra-ovarian injection of platelet rich plasma (PRP) on biomarkers of ovarian reserve as well as IVF outcomes in women with primary ovarian insufficiency (POI) and poor ovarian...
What is the current status of trial NCT04163640?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2020-02-24. Estimated completion is 2023-07-21.
What interventions are being tested in trial NCT04163640?
The interventions under investigation include: intra-ovarian platelet rich plasma injection (OTHER).
Who is sponsoring clinical trial NCT04163640?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.